253 related articles for article (PubMed ID: 28972408)
21. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
van Lierop AH; Hamdy NA; van der Meer RW; Jonker JT; Lamb HJ; Rijzewijk LJ; Diamant M; Romijn JA; Smit JW; Papapoulos SE
Eur J Endocrinol; 2012 Apr; 166(4):711-6. PubMed ID: 22267280
[TBL] [Abstract][Full Text] [Related]
22. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.
Anastasilakis AD; Polyzos SA; Gkiomisi A; Bisbinas I; Gerou S; Makras P
J Clin Endocrinol Metab; 2013 Aug; 98(8):3206-12. PubMed ID: 23788684
[TBL] [Abstract][Full Text] [Related]
23. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.
García-Martín A; Rozas-Moreno P; Reyes-García R; Morales-Santana S; García-Fontana B; García-Salcedo JA; Muñoz-Torres M
J Clin Endocrinol Metab; 2012 Jan; 97(1):234-41. PubMed ID: 22031520
[TBL] [Abstract][Full Text] [Related]
24. Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.
Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
Pediatr Diabetes; 2016 Jun; 17(4):289-99. PubMed ID: 26094958
[TBL] [Abstract][Full Text] [Related]
25. High levels of serum sclerostin and DKK1 in a case of Klippel-Trénaunay syndrome.
Muto P; Lo Gullo A; Mandraffino G; Loddo S; Atteritano M
Osteoporos Int; 2018 Jul; 29(7):1679-1681. PubMed ID: 29774401
[TBL] [Abstract][Full Text] [Related]
26. Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis.
Morabito N; Catalano A; Gaudio A; Morini E; Bruno LM; Basile G; Tsiantouli E; Bellone F; Agostino RM; Piraino B; La Rosa MA; Salpietro C; Lasco A
J Bone Miner Metab; 2016 Sep; 34(5):540-6. PubMed ID: 26204844
[TBL] [Abstract][Full Text] [Related]
27. Comparison of serum Dkk1 (Dickkopf-1) and bone mineral density in patients on bisphosphonate treatment vs no treatment.
Memon AR; Butler JS; O'Riordan MV; Guerin E; Dimitrov BD; Harty JA
J Clin Densitom; 2013; 16(1):118-24. PubMed ID: 22959779
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls.
Wanby P; Nobin R; Von SP; Brudin L; Carlsson M
J Endocrinol Invest; 2016 Aug; 39(8):855-63. PubMed ID: 26850415
[TBL] [Abstract][Full Text] [Related]
29. In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density.
Rossini M; Viapiana O; Adami S; Fracassi E; Idolazzi L; Dartizio C; Povino MR; Orsolini G; Gatti D
Clin Exp Rheumatol; 2015; 33(1):77-83. PubMed ID: 25438096
[TBL] [Abstract][Full Text] [Related]
30. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.
Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P
PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902
[TBL] [Abstract][Full Text] [Related]
31. Sclerostin levels and changes in bone metabolism after bariatric surgery.
Muschitz C; Kocijan R; Marterer C; Nia AR; Muschitz GK; Resch H; Pietschmann P
J Clin Endocrinol Metab; 2015 Mar; 100(3):891-901. PubMed ID: 25490275
[TBL] [Abstract][Full Text] [Related]
32. Changes of serum sclerostin and Dickkopf-1 levels during the menstrual cycle. A pilot study.
Liakou CG; Mastorakos G; Makris K; Fatouros IG; Avloniti A; Marketos H; Antoniou JD; Galanos A; Dontas I; Rizos D; Tournis S
Endocrine; 2016 Nov; 54(2):543-551. PubMed ID: 27601021
[TBL] [Abstract][Full Text] [Related]
33. Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women.
Durosier C; van Lierop A; Ferrari S; Chevalley T; Papapoulos S; Rizzoli R
J Clin Endocrinol Metab; 2013 Sep; 98(9):3873-83. PubMed ID: 23864703
[TBL] [Abstract][Full Text] [Related]
34. The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1.
Gatti D; Viapiana O; Idolazzi L; Fracassi E; Rossini M; Adami S
J Clin Endocrinol Metab; 2011 May; 96(5):1555-9. PubMed ID: 21367927
[TBL] [Abstract][Full Text] [Related]
35. Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study.
Ardawi MS; Rouzi AA; Qari MH
J Clin Endocrinol Metab; 2012 Oct; 97(10):3691-9. PubMed ID: 22865898
[TBL] [Abstract][Full Text] [Related]
36. Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass.
Gombos GC; Bajsz V; Pék E; Schmidt B; Sió E; Molics B; Betlehem J
BMC Musculoskelet Disord; 2016 Jun; 17():254. PubMed ID: 27278385
[TBL] [Abstract][Full Text] [Related]
37. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
Morena M; Jaussent I; Dupuy AM; Bargnoux AS; Kuster N; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
Nephrol Dial Transplant; 2015 Aug; 30(8):1345-56. PubMed ID: 25854266
[TBL] [Abstract][Full Text] [Related]
38. Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover.
Gifre L; Ruiz-Gaspà S; Monegal A; Nomdedeu B; Filella X; Guañabens N; Peris P
Bone; 2013 Nov; 57(1):272-6. PubMed ID: 23981659
[TBL] [Abstract][Full Text] [Related]
39. Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study.
Yang HY; Wu DA; Chen MC; Hsu BG
Diab Vasc Dis Res; 2019 May; 16(3):281-288. PubMed ID: 30547685
[TBL] [Abstract][Full Text] [Related]
40. Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women.
He J; Zhang H; Wang C; Zhang Z; Yue H; Hu W; Gu J; Fu W; Hu Y; Li M; Liu Y; Zheng H; Zhang Z
J Clin Endocrinol Metab; 2014 Apr; 99(4):E665-73. PubMed ID: 24423318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
